Many patients taking GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) experience digestive side effects including nausea, bloating, and altered bowel habits
Elevated cortisol has been shown to impair tendon healing at the cellular level in animal models
First, the medicines do not work for everyone: research suggests up to around 30 percent of people are non-responders, losing less than 5 percent of their body weight
This model serves all 50 states and accepts HSA/FSA accounts, making treatment accessible regardless of employment status or insurance coverage
Heres what sets MediVera apart from newer market entrants and pharmacies without formal accreditation
Benefits Trend Report revealed that 29% of employees would be willing to switch employers to gain access to GLP-1 benefits